Authored By: Sarah
21 Nov 2023

Extracorporeal Membrane Oxygenation Machines Market anticipating USD 243.6 Mn revenue growth through 2023-2027| North America to lead market Landscape worldwide

Regional Growth Analysis and Market Trends 2023-2027

The extracorporeal membrane oxygenation devices market is expected to grow by USD 243.6 million, at a compound annual growth rate (CAGR) of 10.05% between 2022 and 2027, Our research report provides a detailed analysis of the market with insights on trends, drivers, and challenges that are likely to impact market growth. It also provides a competitive analysis of the key market players and their product portfolios.

North America to lead market Landscape of the Extracorporeal Membrane Oxygenation Machines Market during the forecast period

  • The market for extracorporeal membrane oxygenation machines is divided into three categories: veno-venous, arterio-venous, and veno-arterial. It further divides the market into product categories, which include software and ECMO machines. Geographic segmentation, encompassing North America, Europe, Asia, and the Rest of the World (ROW).

extracorporeal membrane oxygenation systems market analysis, extracorporeal membrane oxygenation systems market  trends, extracorporeal membrane oxygenation systems market  analysis, extracorporeal membrane oxygenation systems market  forecast

Fastest growing topography of the Extracorporeal Membrane Oxygenation Machines Market


  • When it comes to the fastest growing topography 37% to the growth of the global market during the forecast period will originate from North America,owing to rising number of lung and heart transplant procedures, the rising incidence of cardiovascular and respiratory disorders, the rising use of technologically advanced medical devices, and these factors are the key drivers of market expansion in the region.
  • Lastly speaking of the fastest growing segment as per trend,the market share of the veno-venous segment gradually increased and will continue to dominate.

Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd and CytoSorbents Europe GmbH,Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp. are some of the market pioneers in this domain are contributing significantly in the market devlopment around the world.These market participants are thoroughly profiled in our research, along with a data-supported analysis.

Technavio has been monitoring the growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking.Learn more about the market dynamics and the aspects that our report's in-depth analysis predicts will have the biggest impact on the market under review.

Read News Read Less
Interested in this report?
Get your sample now!
Technavio